Penbrook Management LLC
Penbrook Management LLC latest Q1_2021 13F filings reported $138,951,000 in market value on this 2021-05-06 report date . The portfolio quarterly return is 0.00%. This fund has 102 securities concentrations of 100% weights.
Penbrook Management LLC largest holding is Novo Nordisk A/S with weight of 13.45% and $11,549,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
| FILE DATE | REPORT PERIOD | QTR YEAR | FILE TYPE | NOS. OF STOCKS | REPORTED VALUE | RETURN |
|---|---|---|---|---|---|---|
| 2021-05-06 | 2021-03-31 | Q1_2021 | 13F-HR/A | 102 | $138,951,000 | 0.00% |
| 2021-04-16 | 2021-03-31 | Q1_2021 | 13F-HR | 101 | $85,893,000 | -39.45% |
| 2021-01-27 | 2020-12-31 | Q4_2020 | 13F-HR | 214 | $141,845,000 | 22.96% |
| 2020-10-23 | 2020-09-30 | Q3_2020 | 13F-HR | 101 | $115,356,000 | 13.47% |
| 2020-07-28 | 2020-06-30 | Q2_2020 | 13F-HR | 109 | $101,664,000 | 30.19% |
| 2020-04-14 | 2020-03-31 | Q1_2020 | 13F-HR | 107 | $78,090,000 | -23.91% |
| 2020-01-16 | 2019-12-31 | Q4_2019 | 13F-HR | 111 | $102,630,000 | 11.36% |
| 2019-10-11 | 2019-09-30 | Q3_2019 | 13F-HR | 108 | $92,164,000 | -1.12% |
| 2019-07-15 | 2019-06-30 | Q2_2019 | 13F-HR | 104 | $93,206,000 | -3.09% |
| 2019-04-24 | 2019-03-31 | Q1_2019 | 13F-HR | 109 | $96,174,000 | 9.76% |
| 2019-02-01 | 2018-12-31 | Q4_2018 | 13F-HR | 110 | $87,626,000 | -16.07% |
| 2018-10-23 | 2018-09-30 | Q3_2018 | 13F-HR | 110 | $104,406,000 | 0.43% |
| 2018-07-30 | 2018-06-30 | Q2_2018 | 13F-HR | 108 | $103,963,000 | 3.95% |
| 2018-04-27 | 2018-03-31 | Q1_2018 | 13F-HR | 107 | $100,013,000 | -9.96% |
| 2018-02-21 | 2017-12-31 | Q4_2017 | 13F-HR | 108 | $111,073,000 | 19.68% |
| 2016-10-27 | 2016-09-30 | Q3_2016 | 13F-HR | 107 | $92,805,000 | 2.32% |
| 2016-08-05 | 2016-06-30 | Q2_2016 | 13F-HR | 107 | $90,698,000 | -0.14% |